Journal of the American Chemical Society · 2020 · 31 citations · 26 references
PharmacyMedicinal ChemistryPharmacologyDrug DeliveryDrug DiscoveryProdrug DesignDiabetes MellitusDiabetes Mellitus BiochemistryLigand BindingPancreatic HormonesProdrug Activation MechanismsTargeted Prodrug DeliveryBeta Cell BiologyBeta-cell DysfunctionCell Type SpecificityFine-tuningPancreatic Beta-cell FunctionPancreatic Islet CellsProdrug TargetingTargeting
or other cell-types in an organismal context will be immensely valuable in advancing diabetes research and therapeutic development. Here, we leverage the unusually high Zn(II) concentration in β-cells to develop a Zn(II)-based prodrug system to selectively and tracelessly deliver bioactive small molecules and fluorophores to β-cells. The Zn(II)-targeting mechanism enriches the inactive cargo in β-cells as compared to other pancreatic cells; importantly, Zn(II)-mediated hydrolysis triggers cargo activation. This prodrug system, with modular components that allow for fine-tuning selectivity, should enable the safer and more effective targeting of β-cells.
26
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Alexandra E. Butler, Juliette Janson, Susan Bonner‐Weir et al. · Diabetes · 2003 · 4K citations
Medicine, Endocrinology, Physiology +17
Generation of Functional Human Pancreatic β Cells In Vitro
Felicia W. Pagliuca, Jeffrey R. Millman, Mads Gürtler et al. · Cell · 2014 · 2K citations · Full text